BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35112281)

  • 1. Association Between the Frequent Use of Perineal Talcum Powder Products and Ovarian Cancer: a Systematic Review and Meta-analysis.
    Woolen SA; Lazar AA; Smith-Bindman R
    J Gen Intern Med; 2022 Aug; 37(10):2526-2532. PubMed ID: 35112281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perineal use of talcum powder and endometrial cancer risk.
    Karageorgi S; Gates MA; Hankinson SE; De Vivo I
    Cancer Epidemiol Biomarkers Prev; 2010 May; 19(5):1269-75. PubMed ID: 20406962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perineal powder use and risk of ovarian cancer.
    Houghton SC; Reeves KW; Hankinson SE; Crawford L; Lane D; Wactawski-Wende J; Thomson CA; Ockene JK; Sturgeon SR
    J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25214560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perineal talc exposure and subsequent epithelial ovarian cancer: a case-control study.
    Wong C; Hempling RE; Piver MS; Natarajan N; Mettlin CJ
    Obstet Gynecol; 1999 Mar; 93(3):372-6. PubMed ID: 10074982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perineal application of cosmetic talc and risk of invasive epithelial ovarian cancer: a meta-analysis of 11,933 subjects from sixteen observational studies.
    Huncharek M; Geschwind JF; Kupelnick B
    Anticancer Res; 2003; 23(2C):1955-60. PubMed ID: 12820486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Powder Use in the Genital Area With Risk of Ovarian Cancer.
    O'Brien KM; Tworoger SS; Harris HR; Anderson GL; Weinberg CR; Trabert B; Kaunitz AM; D'Aloisio AA; Sandler DP; Wentzensen N
    JAMA; 2020 Jan; 323(1):49-59. PubMed ID: 31910280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Talcum powder induces malignant transformation in normal human primary ovarian epithelial cells.
    Harper AK; Wang X; Fan R; Kirsch Mangu T; Fletcher NM; Morris RT; Saed GM
    Minerva Obstet Gynecol; 2023 Apr; 75(2):150-157. PubMed ID: 34825792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of talcum powder and endometrial cancer risk.
    Neill AS; Nagle CM; Spurdle AB; Webb PM
    Cancer Causes Control; 2012 Mar; 23(3):513-9. PubMed ID: 22245995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical review of the association between perineal use of talc powder and risk of ovarian cancer.
    Kadry Taher M; Farhat N; Karyakina NA; Shilnikova N; Ramoju S; Gravel CA; Krishnan K; Mattison D; Wen SW; Krewski D
    Reprod Toxicol; 2019 Dec; 90():88-101. PubMed ID: 31472245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perineal Talc Use and Ovarian Cancer: A Systematic Review and Meta-Analysis.
    Penninkilampi R; Eslick GD
    Epidemiology; 2018 Jan; 29(1):41-49. PubMed ID: 28863045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genital use of talc and risk of ovarian cancer: a meta-analysis.
    Berge W; Mundt K; Luu H; Boffetta P
    Eur J Cancer Prev; 2018 May; 27(3):248-257. PubMed ID: 28079603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.
    Rizzuto I; Behrens RF; Smith LA
    Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD008215. PubMed ID: 23943232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is aspirin use associated with a decreased risk of ovarian cancer? A systematic review and meta-analysis of observational studies with dose-response analysis.
    Zhang D; Bai B; Xi Y; Wang T; Zhao Y
    Gynecol Oncol; 2016 Aug; 142(2):368-77. PubMed ID: 27151430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perineal exposure to talc and ovarian cancer risk.
    Harlow BL; Cramer DW; Bell DA; Welch WR
    Obstet Gynecol; 1992 Jul; 80(1):19-26. PubMed ID: 1603491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of local vancomycin powder to decrease surgical site infections: a meta-analysis.
    Chiang HY; Herwaldt LA; Blevins AE; Cho E; Schweizer ML
    Spine J; 2014 Mar; 14(3):397-407. PubMed ID: 24373682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genital powder exposure and the risk of epithelial ovarian cancer.
    Rosenblatt KA; Weiss NS; Cushing-Haugen KL; Wicklund KG; Rossing MA
    Cancer Causes Control; 2011 May; 22(5):737-42. PubMed ID: 21516319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of exposure to long working hours on stroke: A systematic review and meta-analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury.
    Descatha A; Sembajwe G; Pega F; Ujita Y; Baer M; Boccuni F; Di Tecco C; Duret C; Evanoff BA; Gagliardi D; Godderis L; Kang SK; Kim BJ; Li J; Magnusson Hanson LL; Marinaccio A; Ozguler A; Pachito D; Pell J; Pico F; Ronchetti M; Roquelaure Y; Rugulies R; Schouteden M; Siegrist J; Tsutsumi A; Iavicoli S
    Environ Int; 2020 Sep; 142():105746. PubMed ID: 32505015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Talc, body powder, and ovarian cancer: A summary of the epidemiologic evidence.
    Wentzensen N; O'Brien KM
    Gynecol Oncol; 2021 Oct; 163(1):199-208. PubMed ID: 34366148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perineal powder exposure and the risk of ovarian cancer.
    Cook LS; Kamb ML; Weiss NS
    Am J Epidemiol; 1997 Mar; 145(5):459-65. PubMed ID: 9048520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genital talc exposure and risk of ovarian cancer.
    Cramer DW; Liberman RF; Titus-Ernstoff L; Welch WR; Greenberg ER; Baron JA; Harlow BL
    Int J Cancer; 1999 May; 81(3):351-6. PubMed ID: 10209948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.